Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
83 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07407192 | Toxicity Outcomes of Simultaneous Integrated Boost in Adjuvant Breast Radiotherapy Acronym(SIB) | completed | N/A | 93 | Institute of Oncology LjubljanaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407205 | Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer | active not recruiting | N/A | 30 | Institute of Oncology LjubljanaOTHER | 1 | Feb 17, 2026 |
| clinicaltrials |
| NCT07407218 | Fecal Microbiota And Metabolites In Head And Neck Cancer Patients Receiving (Chemo)Radiotherapy | completed | N/A | 58 | Institute of Oncology LjubljanaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407231 | Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC) | recruiting | N/A | 18 | Institute of Oncology LjubljanaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07407244 | Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer(AKRA) | active not recruiting | N/A | 268 | Institute of Oncology LjubljanaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07406646 | Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1)(EXO-RENAL1) | completed | N/A | 91 | Institute of Oncology LjubljanaOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06923787 | Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study(PILDI) | recruiting | Phase 2 | 100 | Institute of Oncology LjubljanaOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT00868491 | Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer | completed | Phase 2 | 30 | Institute of Oncology LjubljanaOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT04007068 | FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy | completed | — | 30 | Institute of Oncology LjubljanaOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT05878977 | Biomarkers in Immunotherapy of Melanoma | recruiting | N/A | 150 | Institute of Oncology LjubljanaOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT06648148 | Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer | recruiting | — | 200 | Institute of Oncology LjubljanaOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT04679597 | Total Neoadjuvant Therapy Versus Standard Therapy of Locally Advanced Rectal Cancer With High Risk Factors for Failure | completed | — | 161 | Institute of Oncology LjubljanaOTHER | 0 | Oct 17, 2024 | clinicaltrials |
| NCT04760327 | Electrochemotherapy of Gynecological Cancers(GynECT) | recruiting | Phase 2 | 30 | Institute of Oncology LjubljanaOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT05611658 | Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CT | completed | — | 23 | Institute of Oncology LjubljanaOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT05631379 | Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma | completed | — | 100 | Institute of Oncology LjubljanaOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT06060990 | Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers | recruiting | N/A | 20 | Institute of Oncology LjubljanaOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT05156177 | Correlation of Fecal Microbiome and Its Metabolites With Outcome of Radiotherapy in Head and Neck Carcinoma(COMRAD-HNSCC) | unknown | — | 40 | Institute of Oncology LjubljanaOTHER | 1 | Mar 5, 2024 | clinicaltrials |
| NCT05916690 | Electrochemotherapy for the Treatment of Vulvar Cancer | unknown | N/A | 20 | Institute of Oncology LjubljanaOTHER | 1 | Jan 19, 2024 | clinicaltrials |
| NCT06207747 | Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients | unknown | N/A | 70 | Institute of Oncology LjubljanaOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT05077033 | Intratumoral phIL12 GET(SmartGeneH&N) | completed | Phase 1 | 9 | Institute of Oncology LjubljanaOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT02352259 | Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II | completed | Phase 2 | 23 | Institute of Oncology LjubljanaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT01264952 | Treatment of Liver Metastases With Electrochemotherapy(ECTJ) | completed | Phase 1 / Phase 2 | 16 | Institute of Oncology LjubljanaOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02268006 | IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment(BISER) | unknown | Phase 2 | 50 | Institute of Oncology LjubljanaOTHER | 1 | Oct 20, 2014 | clinicaltrials |
| NCT01572883 | Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast Cancer | completed | — | 175 | Institute of Oncology LjubljanaOTHER | 1 | Oct 16, 2014 | clinicaltrials |
| NCT00689702 | Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer(XERT) | unknown | Phase 2 | 43 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00842686 | Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study(CRAB) | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01152164 | Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer | unknown | — | 167 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01269489 | Health-related Quality of Life in General Slovenian Population | unknown | — | 600 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01472653 | Treatment Selection According to Skin Reaction to Cetuximab | unknown | Phase 2 | 120 | Institute of Oncology LjubljanaOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01489332 | Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Dec 9, 2011 | clinicaltrials |
| NCT01281800 | Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma(AGILI) | unknown | Phase 2 | 72 | Institute of Oncology LjubljanaOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT01243632 | Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment | completed | Phase 2 | 78 | Institute of Oncology LjubljanaOTHER | 1 | Nov 18, 2010 | clinicaltrials |
| NCT01152710 | Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer | completed | Phase 2 | 57 | Institute of Oncology LjubljanaOTHER | 1 | Jun 29, 2010 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials